P1126: MOSUNETUZUMAB IS EFFICACIOUS AND WELL TOLERATED IN PATIENTS AGED <65 AND ≥65 YEARS WITH RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA AND ≥2 PRIOR THERAPIES: SUBGROUP ANALYSIS OF A PIVOTAL PHASE II STUDY

Detalles Bibliográficos
Autores principales: Matasar, M., Bartlett, N. L., Sehn, L. H., Schuster, S. J., Assouline, S., Giri, P., Kuruvilla, J., Canales, M., Dietrich, S., Fay, K., Ku, M., Nastoupil, L. J., Wei, M. C., Yin, S., To, I., Turner, D., Huang, H., Min, J., Penuel, E., Budde, L. E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430131/
http://dx.doi.org/10.1097/01.HS9.0000847372.57687.d4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430131/
http://dx.doi.org/10.1097/01.HS9.0000847372.57687.d4

Ejemplares similares